Samsung becomes largest shareholder in Element Biosciences with US$175 mln investment
SEOUL, June 10 (Yonhap) -- Samsung Electronics Co. said Wednesday it has invested US$175 million in an expanded Series E funding round for U.S.-based genomics technology company Element Biosciences, becoming the company's largest shareholder.